CEACAM5 and carcinoma: In 661 patients with pT2–4 carcinomas who were treated by cystectomy, the CEA staining intensity was not associated with overall, tumour specific or recurrence‐free survival (Figure 2A–C) This also hold true if subsets of pT2, pT3 and pT4 cancers were separately analysed (data not shown).